EDAP TMS S.A. (EDAP)
USD 2.16
(-12.2%)
USD 2.16
(-12.2%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 44.22 Million EUR | 52.26% |
| 2022 | 28.45 Million EUR | 42.0% |
| 2021 | 20.03 Million EUR | 10.63% |
| 2020 | 18.11 Million EUR | -3.68% |
| 2019 | 18.8 Million EUR | 3.13% |
| 2018 | 18.23 Million EUR | 8.3% |
| 2017 | 16.83 Million EUR | 5.09% |
| 2016 | 16.02 Million EUR | 20.47% |
| 2015 | 13.29 Million EUR | 2.78% |
| 2014 | 12.93 Million EUR | 7.16% |
| 2013 | 12.07 Million EUR | -3.13% |
| 2012 | 12.46 Million EUR | 9.78% |
| 2011 | 11.35 Million EUR | -14.45% |
| 2010 | 13.27 Million EUR | -4.34% |
| 2009 | 13.87 Million EUR | 0.53% |
| 2008 | 13.8 Million EUR | 3.85% |
| 2007 | 13.28 Million EUR | 16.44% |
| 2006 | 11.41 Million EUR | 16.3% |
| 2005 | 9.81 Million EUR | 5.4% |
| 2004 | 9.3 Million EUR | -30.92% |
| 2003 | 13.47 Million EUR | 1.74% |
| 2002 | 13.24 Million EUR | 0.99% |
| 2001 | 13.11 Million EUR | -22.12% |
| 2000 | 16.84 Million EUR | 2.04% |
| 1999 | 16.5 Million EUR | -6.93% |
| 1998 | 17.73 Million EUR | 2.14% |
| 1997 | 17.36 Million EUR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 12.12 Million EUR | 7.09% |
| 2024 Q1 | 11.26 Million EUR | -3.98% |
| 2023 Q4 | 11.73 Million EUR | 20.79% |
| 2023 Q1 | 12.58 Million USD | 43.24% |
| 2023 Q3 | 9.71 Million EUR | -1.68% |
| 2023 FY | 43.31 Million EUR | 52.26% |
| 2023 Q2 | 9.88 Million EUR | -21.51% |
| 2022 Q1 | 5.86 Million EUR | 2.05% |
| 2022 FY | 28.45 Million EUR | 42.0% |
| 2022 Q4 | 8.78 Million EUR | 22.63% |
| 2022 Q3 | 7.16 Million EUR | 8.1% |
| 2022 Q2 | 6.62 Million EUR | 12.97% |
| 2021 FY | 20.03 Million EUR | 10.63% |
| 2021 Q4 | 5.75 Million EUR | 4.36% |
| 2021 Q3 | 5.51 Million EUR | 18.67% |
| 2021 Q2 | 4.64 Million EUR | 12.37% |
| 2021 Q1 | 4.13 Million EUR | -22.18% |
| 2020 Q3 | 4.25 Million EUR | 5.84% |
| 2020 Q1 | 4.52 Million EUR | -10.63% |
| 2020 Q2 | 4.02 Million EUR | -11.06% |
| 2020 FY | 18.11 Million EUR | -3.68% |
| 2020 Q4 | 5.31 Million EUR | 24.74% |
| 2019 Q1 | 4.65 Million EUR | -9.31% |
| 2019 Q2 | 4.67 Million EUR | 0.43% |
| 2019 Q4 | 5.06 Million EUR | -63.18% |
| 2019 FY | 18.8 Million EUR | 3.13% |
| 2019 Q3 | 13.74 Million EUR | 193.8% |
| 2018 Q4 | 5.13 Million EUR | 26.7% |
| 2018 FY | 18.23 Million EUR | 8.3% |
| 2018 Q3 | 4.05 Million EUR | -12.46% |
| 2018 Q2 | 4.63 Million EUR | 4.92% |
| 2018 Q1 | 4.41 Million EUR | -4.31% |
| 2017 Q2 | 4.44 Million EUR | 11.96% |
| 2017 Q4 | 4.61 Million EUR | 21.15% |
| 2017 FY | 16.83 Million EUR | 5.09% |
| 2017 Q1 | 3.97 Million EUR | -18.43% |
| 2017 Q3 | 3.8 Million EUR | -14.37% |
| 2016 Q4 | 4.86 Million EUR | 28.61% |
| 2016 FY | 16.02 Million EUR | 20.47% |
| 2016 Q2 | 3.8 Million EUR | 6.94% |
| 2016 Q1 | 3.55 Million EUR | -4.12% |
| 2016 Q3 | 3.78 Million EUR | -0.55% |
| 2015 Q2 | 3.54 Million EUR | 10.81% |
| 2015 Q3 | 2.83 Million EUR | -20.12% |
| 2015 Q4 | 3.71 Million EUR | 30.98% |
| 2015 FY | 13.29 Million EUR | 2.78% |
| 2015 Q1 | 3.2 Million EUR | -7.38% |
| 2014 Q2 | 3.4 Million EUR | 13.37% |
| 2014 Q3 | 3.06 Million EUR | -10.01% |
| 2014 Q4 | 3.45 Million EUR | 12.72% |
| 2014 Q1 | 3 Million EUR | -0.69% |
| 2014 FY | 12.93 Million EUR | 7.16% |
| 2013 Q3 | 2.57 Million EUR | -16.59% |
| 2013 FY | 12.07 Million EUR | -3.13% |
| 2013 Q1 | 3.38 Million EUR | -6.82% |
| 2013 Q4 | 3.02 Million EUR | 17.6% |
| 2013 Q2 | 3.08 Million EUR | -8.91% |
| 2012 Q4 | 3.63 Million EUR | 40.49% |
| 2012 FY | 12.46 Million EUR | 9.78% |
| 2012 Q3 | 2.58 Million EUR | -22.28% |
| 2012 Q1 | 2.9 Million EUR | -8.29% |
| 2012 Q2 | 3.33 Million EUR | 14.51% |
| 2011 Q4 | 3.17 Million EUR | 15.14% |
| 2011 Q2 | 2.78 Million EUR | 5.22% |
| 2011 Q1 | 2.64 Million EUR | -22.06% |
| 2011 FY | 11.35 Million EUR | -14.45% |
| 2011 Q3 | 2.75 Million EUR | -1.08% |
| 2010 FY | 13.27 Million EUR | -4.34% |
| 2010 Q4 | 3.39 Million EUR | 12.27% |
| 2010 Q1 | 3.1 Million EUR | -13.31% |
| 2010 Q2 | 3.75 Million EUR | 21.06% |
| 2010 Q3 | 3.02 Million EUR | -19.42% |
| 2009 Q3 | 3.2 Million EUR | -13.13% |
| 2009 Q1 | 3.39 Million EUR | -8.56% |
| 2009 FY | 13.87 Million EUR | 0.53% |
| 2009 Q4 | 3.57 Million EUR | 11.47% |
| 2009 Q2 | 3.69 Million EUR | 8.75% |
| 2008 Q1 | 3.38 Million EUR | -10.43% |
| 2008 FY | 13.8 Million EUR | 3.85% |
| 2008 Q4 | 3.71 Million EUR | 11.93% |
| 2008 Q3 | 3.31 Million EUR | -2.05% |
| 2008 Q2 | 3.38 Million EUR | 0.19% |
| 2007 Q1 | - EUR | -100.0% |
| 2007 Q2 | - EUR | 0.0% |
| 2007 Q3 | 334.26 Thousand EUR | 0.0% |
| 2007 FY | 13.28 Million EUR | 16.44% |
| 2007 Q4 | 3.77 Million EUR | 1029.36% |
| 2006 Q1 | 2.75 Million EUR | -67.17% |
| 2006 Q4 | 3.69 Million EUR | 31.96% |
| 2006 Q3 | 2.79 Million EUR | -6.97% |
| 2006 Q2 | 3 Million EUR | 8.96% |
| 2006 FY | 11.41 Million EUR | 16.3% |
| 2005 Q2 | 493.08 Thousand EUR | 8.52% |
| 2005 Q1 | 454.37 Thousand EUR | -94.45% |
| 2005 FY | 9.81 Million EUR | 5.4% |
| 2005 Q4 | 8.4 Million EUR | 1882.25% |
| 2005 Q3 | 423.9 Thousand EUR | -14.03% |
| 2004 Q1 | -186 Thousand EUR | -101.66% |
| 2004 Q4 | 8.19 Million EUR | 2219.91% |
| 2004 Q2 | 383.68 Thousand EUR | 306.28% |
| 2004 FY | 9.3 Million EUR | -30.92% |
| 2004 Q3 | 353.03 Thousand EUR | -7.99% |
| 2003 Q3 | 766.91 Thousand EUR | -6.23% |
| 2003 Q1 | 723.96 Thousand EUR | -93.53% |
| 2003 Q2 | 817.83 Thousand EUR | 12.97% |
| 2003 Q4 | 11.22 Million EUR | 1363.8% |
| 2003 FY | 13.47 Million EUR | 1.74% |
| 2002 Q4 | 11.19 Million EUR | 1394.15% |
| 2002 FY | 13.24 Million EUR | 0.99% |
| 2002 Q3 | 749.36 Thousand EUR | 0.0% |
| 2002 Q2 | - EUR | 0.0% |
| 2002 Q1 | - EUR | 100.0% |
| 2001 Q3 | - EUR | 0.0% |
| 2001 Q2 | - EUR | 0.0% |
| 2001 Q1 | - EUR | 100.0% |
| 2001 FY | 13.11 Million EUR | -22.12% |
| 2001 Q4 | -28.33 Million EUR | 0.0% |
| 2000 Q3 | - EUR | 0.0% |
| 2000 Q1 | - EUR | 100.0% |
| 2000 Q2 | - EUR | 0.0% |
| 2000 FY | 16.84 Million EUR | 2.04% |
| 2000 Q4 | -31.07 Million EUR | 0.0% |
| 1999 Q2 | - EUR | 0.0% |
| 1999 FY | 16.5 Million EUR | -6.93% |
| 1999 Q1 | - EUR | 100.0% |
| 1999 Q4 | -27.28 Million EUR | 0.0% |
| 1999 Q3 | - EUR | 0.0% |
| 1998 Q3 | - EUR | 0.0% |
| 1998 Q1 | - EUR | 100.0% |
| 1998 FY | 17.73 Million EUR | 2.14% |
| 1998 Q4 | -29.33 Million EUR | 0.0% |
| 1998 Q2 | - EUR | 0.0% |
| 1997 Q3 | - EUR | 0.0% |
| 1997 Q4 | -33.54 Million EUR | 0.0% |
| 1997 FY | 17.36 Million EUR | 0.0% |
| 1997 Q1 | - EUR | 0.0% |
| 1997 Q2 | - EUR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Alphatec Holdings, Inc. | 483.59 Million USD | 90.855% |
| Nemaura Medical Inc. | 7.13 Million USD | -519.488% |
| NeuroPace, Inc. | 75.29 Million USD | 41.266% |
| LENSAR, Inc. | 33.33 Million USD | -32.661% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 13.419% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 36.873% |
| Apyx Medical Corporation | 51.01 Million USD | 13.317% |
| Cutera, Inc. | 197.72 Million USD | 77.633% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -78.459% |
| BioSig Technologies, Inc. | 28.53 Million USD | -55.009% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 21.835% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 94.713% |
| Axonics, Inc. | 270.2 Million USD | 83.633% |
| IRIDEX Corporation | 31.81 Million USD | -39.008% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 75.461% |
| TELA Bio, Inc. | 84.18 Million USD | 47.469% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -418.331% |
| RxSight, Inc. | 103.85 Million USD | 57.416% |
| Align Technology, Inc. | 2.07 Billion USD | 97.871% |
| INVO Bioscience, Inc. | 7.85 Million USD | -463.127% |
| electroCore, Inc. | 32.03 Million USD | -38.066% |
| Telesis Bio, Inc. | 63.48 Million USD | 30.344% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 55.081% |
| Quipt Home Medical Corp. | 148.66 Million USD | 70.253% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 76.904% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -277.241% |
| Lucid Diagnostics Inc. | 42.43 Million USD | -4.223% |
| Dynatronics Corporation | 9.9 Million USD | -346.345% |
| Modular Medical, Inc. | 17.52 Million USD | -152.29% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -119.072% |
| Talis Biomedical Corporation | 67.18 Million USD | 34.177% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -289.266% |
| InMode Ltd. | 215.68 Million USD | 79.496% |
| Envoy Medical, Inc. | 17.89 Million USD | -147.089% |
| Bruker Corporation | 1.07 Billion USD | 95.891% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -254.104% |
| DexCom, Inc. | 1.69 Billion USD | 97.385% |
| Nexalin Technology, Inc. | 5.78 Million USD | -664.942% |
| PAVmed Inc | 64.82 Million USD | 31.782% |
| Viveve Medical, Inc. | 22.17 Million USD | -99.45% |
| Cerus Corporation | 143.15 Million USD | 69.108% |
| Movano Inc. | 29.69 Million USD | -48.953% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 67.783% |
| Nexalin Technology, Inc. | 5.78 Million USD | -664.942% |
| IceCure Medical Ltd | 16.87 Million USD | -162.053% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 92.641% |
| enVVeno Medical Corporation | 25.23 Million USD | -75.228% |
| 908 Devices Inc. | 68.08 Million USD | 35.041% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -22.64% |
| Orthofix Medical Inc. | 667.42 Million USD | 93.374% |
| Surmodics, Inc. | 98.69 Million USD | 55.192% |
| Nuwellis, Inc. | 22.61 Million USD | -95.569% |
| Outset Medical, Inc. | 198.77 Million USD | 77.751% |
| Venus Concept Inc. | 80.47 Million USD | 45.047% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 90.082% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 78.254% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 21.024% |
| Aethlon Medical, Inc. | 12.27 Million USD | -260.203% |
| Inogen, Inc. | 236.08 Million USD | 81.268% |
| IRadimed Corporation | 30.12 Million USD | -46.812% |
| MaxCyte, Inc. | 84.84 Million USD | 47.877% |
| Pulmonx Corporation | 112.68 Million USD | 60.755% |
| PAVmed Inc. | 64.82 Million USD | 31.782% |
| iCAD, Inc. | 22.22 Million USD | -98.983% |
| OrthoPediatrics Corp. | 137.01 Million USD | 67.724% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -1153.516% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -150.802% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -256.307% |
| SI-BONE, Inc. | 156.35 Million USD | 71.715% |
| Semler Scientific, Inc. | 38.94 Million USD | -13.558% |
| Beyond Air, Inc. | 61.7 Million USD | 28.324% |
| FONAR Corporation | 28.6 Million USD | -54.604% |
| AxoGen, Inc. | 149.33 Million USD | 70.386% |
| Biotricity, Inc. | 17.18 Million USD | -157.347% |
| Cytosorbents Corporation | 48.33 Million USD | 8.509% |
| ZimVie Inc. | 275.12 Million USD | 83.926% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 75.028% |
| Inari Medical, Inc. | 448.59 Million USD | 90.142% |
| UFP Technologies, Inc. | 58.08 Million USD | 23.869% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -1153.516% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -797.476% |
| Sight Sciences, Inc. | 126.44 Million USD | 65.026% |
| Insulet Corporation | 939.9 Million USD | 95.295% |
| Profound Medical Corp. | 33.6 Million USD | -31.607% |
| Bioventus Inc. | 409.91 Million USD | 89.212% |
| InspireMD, Inc. | 22.95 Million USD | -92.697% |
| BrainsWay Ltd. | 28.01 Million USD | -57.841% |
| BIOLASE, Inc. | 34.66 Million USD | -27.59% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -599.936% |
| Tenon Medical, Inc. | 16.96 Million USD | -160.632% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -498.187% |
| CVRx, Inc. | 76.14 Million USD | 41.919% |
| AdaptHealth Corp. | 1.07 Billion USD | 95.897% |
| Sintx Technologies, Inc. | 15.2 Million USD | -190.928% |
| Acutus Medical, Inc. | 11.22 Million USD | -294.013% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -77.279% |
| NanoVibronix, Inc. | 4.97 Million USD | -789.282% |
| Quanterix Corporation | 118.1 Million USD | 62.554% |
| LivaNova PLC | 843.54 Million USD | 94.757% |
| Co-Diagnostics, Inc. | 44.1 Million USD | -0.275% |
| Varex Imaging Corporation | 224.8 Million USD | 80.327% |
| Vivani Medical, Inc. | 26.96 Million USD | -64.005% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -277.241% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -206.218% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 88.738% |
| TransMedics Group, Inc. | 182.82 Million USD | 75.81% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -57.577% |
| NeuroMetrix, Inc. | 11.09 Million USD | -298.453% |
| Spectral AI, Inc. | 20.86 Million USD | -111.963% |
| Hyperfine, Inc. | 52.87 Million USD | 16.356% |
| Establishment Labs Holdings Inc. | 172 Million USD | 74.289% |
| Biomerica, Inc. | 6.97 Million USD | -533.763% |
| Bone Biologics Corporation | 9.42 Million USD | -369.056% |
| AVITA Medical, Inc. | 80.77 Million USD | 45.253% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -328.892% |
| Silk Road Medical, Inc | 186.35 Million USD | 76.269% |